Top Page
Alibaba Group Holding Ltd.
(9988)
Alibaba Group Holding Ltd. (9988) vs. iShares MSCI Hong Kong ETF (EWH)
Alibaba Group Holding Ltd. Business Overview & Revenue Model
Alibaba Group Holding Ltd. Earnings Call Summary
Alibaba Group Holding Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00T | 996.35B | 941.17B | 868.69B | 853.06B | 717.29B |
| Gross Profit | 412.15B | 398.06B | 354.85B | 318.99B | 313.61B | 296.08B |
| EBITDA | 188.35B | 207.51B | 164.01B | 153.11B | 128.23B | 217.96B |
| Net Income | 146.37B | 130.11B | 80.01B | 72.78B | 62.25B | 150.58B |
Balance Sheet | ||||||
| Total Assets | 1.85T | 1.80T | 1.76T | 1.75T | 1.70T | 1.69T |
| Cash, Cash Equivalents and Short-Term Investments | 416.42B | 428.09B | 571.03B | 524.47B | 455.08B | 483.44B |
| Total Debt | 232.10B | 248.11B | 205.61B | 195.57B | 176.60B | 181.44B |
| Total Liabilities | 753.77B | 714.12B | 652.23B | 630.12B | 613.36B | 606.58B |
| Stockholders Equity | 1.01T | 1.01T | 986.54B | 989.66B | 948.48B | 937.47B |
Cash Flow | ||||||
| Free Cash Flow | 25.90B | 77.54B | 149.66B | 165.40B | 89.44B | 188.60B |
| Operating Cash Flow | 150.54B | 163.51B | 182.59B | 199.75B | 142.76B | 231.79B |
| Investing Cash Flow | -131.26B | -185.41B | -21.82B | -135.51B | -198.59B | -244.19B |
| Financing Cash Flow | -59.36B | -76.22B | -108.24B | -65.62B | -64.45B | 30.08B |
Alibaba Group Holding Ltd. Technical Analysis
Alibaba Group Holding Ltd. Risk Analysis
Alibaba Group Holding Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | 425.49B | 9.30 | 17.02% | 2.95% | 14.18% | 32.25% | |
74 Outperform | HK$3.32T | 18.50 | 15.15% | 1.13% | 5.08% | 127.82% | |
64 Neutral | 624.55B | 19.40 | 16.01% | ― | 17.67% | 33.64% | |
57 Neutral | 1.93B | -9.54 | -4.73% | ― | 7.51% | 30.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
Alibaba Group Holding Ltd. Corporate Events
Alibaba Group Holding Limited has announced the record date for determining eligibility to attend and vote at its upcoming annual general meeting, set for August 5, 2025. The meeting will be held virtually, and shareholders of ordinary shares and American Depositary Shares (ADS) will have specific instructions on how to participate. This announcement highlights the company’s commitment to engaging its shareholders and ensuring their participation in corporate governance, despite the complexities of time zone differences and the weighted voting rights structure that characterizes its shareholding.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$135.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced the filing of a Form F-4 with the U.S. Securities and Exchange Commission, related to an offer to exchange its outstanding senior notes for notes that will be registered under the U.S. Securities Act of 1933. This move aims to enhance the tradability of its securities, potentially impacting the company’s financial operations and providing more flexibility for stakeholders.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$135.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. has announced the pricing of its HK$12.023 billion Zero Coupon Exchangeable Bonds, which are linked to Alibaba Health Information Technology Limited shares. This move is expected to strengthen Alibaba’s position in the healthcare sector, as the bonds can be exchanged for shares of Alibaba Health, a key subsidiary. The bonds are set to mature in 2032, with various redemption options available, reflecting Alibaba’s strategic focus on leveraging its healthcare investments to drive industry transformation.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited announced a proposed offering of approximately HK$12 billion in zero coupon exchangeable bonds, linked to its subsidiary Alibaba Health Information Technology Limited. The proceeds from this bond offering are intended for general corporate purposes, including investments in cloud infrastructure and international commerce. This strategic financial move is expected to support Alibaba’s ongoing collaboration with Alibaba Health and drive transformation in the ‘AI + Healthcare’ industry. Additionally, the bond offering may lead to hedging activities that could impact the market price of Alibaba Health shares.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced a voluntary update on its share repurchase program, revealing that it repurchased 56 million ordinary shares, equivalent to 7 million American depositary shares (ADSs), for a total of US$805 million during the quarter ending June 30, 2025. This move is part of a broader strategy to manage its capital structure and return value to shareholders, with US$19.3 billion remaining authorized for repurchase through March 2027. The announcement reflects Alibaba’s ongoing efforts to optimize its shareholding structure amidst a weighted voting rights framework, which could impact investor perceptions and market dynamics.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced the grant of awards involving 7,687,091 underlying shares to certain employees under its 2024 Plan. These awards, representing approximately 0.04% of the total shares in issue, are part of a weighted voting rights structure and are not subject to shareholder approval. The awards have varied vesting periods, with some vesting within 12 months, and do not include performance targets. A clawback mechanism is in place to ensure compliance with company policies. This grant reflects Alibaba’s strategy to incentivize its workforce and align employee interests with company growth, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited announced an adjustment to the conversion rate of its convertible senior notes due 2031, following the declaration of dividends for fiscal year 2025. This adjustment increases the maximum number of ordinary shares issuable upon full conversion of the notes, potentially impacting shareholder value and market perception.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited announced a two-part dividend distribution totaling US$0.25 per ordinary share or US$2.00 per ADS, which includes a regular annual cash dividend and a one-time extraordinary cash dividend from the proceeds of business and financial asset dispositions. The record date for the dividend is June 12, 2025, with payments expected around July 3, 2025, for ordinary shares and July 10, 2025, for ADS holders. The announcement highlights the logistics for shareholders and ADS holders, including the temporary suspension of conversions between ordinary shares and ADSs, but assures that trading on stock exchanges will not be affected.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced the grant of awards pursuant to its 2024 Plan, involving 53,429,597 underlying shares, representing approximately 0.28% of the total shares in issue. These awards are granted to certain employees and are subject to mixed vesting schedules and performance targets, with a clawback mechanism in place for specific events. This move reflects Alibaba’s commitment to incentivizing its workforce and aligning employee performance with the company’s strategic goals, potentially impacting its operational efficiency and market competitiveness.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited has announced the filing of a Form SD with the U.S. Securities and Exchange Commission for the year 2024, in compliance with the U.S. Securities Exchange Act. This filing pertains to the use and origin of conflict minerals, such as gold, tantalum, tin, and tungsten, in their products. The announcement highlights Alibaba’s commitment to regulatory compliance and transparency, potentially impacting its reputation and stakeholder trust.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced the filing of a Form S-8 with the U.S. Securities and Exchange Commission to register an additional 74.4 million ordinary shares under its 2024 Equity Incentive Plan. This move is part of Alibaba’s strategy to enhance its equity incentive offerings, potentially impacting its stock market performance and shareholder value.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited announced that its shareholder, SoftBank Group Corp., has filed a Schedule 13G with the U.S. Securities and Exchange Commission to report its beneficial ownership in Alibaba as of March 31, 2025. This filing is a regulatory requirement for entities owning more than 5% of a security listed on a U.S. national securities exchange. The announcement underscores the importance of regulatory compliance and transparency in Alibaba’s operations, potentially impacting investor perceptions and market dynamics.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. announced the filing of a Form 13F with the U.S. Securities and Exchange Commission, detailing its holdings in publicly traded companies as an institutional investment manager for the quarter ending March 31, 2025. This filing, required for companies with investment discretion over $100 million in equity securities, highlights Alibaba’s significant role in investment management, despite its primary focus on e-commerce and technology, and underscores its compliance with regulatory requirements.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Ltd. has announced a special cash dividend of USD 0.11875 per share for the financial year ending March 31, 2025. The dividend reflects Alibaba’s strong financial performance and commitment to returning value to shareholders, with the payment date set for July 3, 2025, and the record date on June 12, 2025.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group Holding Limited has announced a final ordinary cash dividend of USD 0.13125 per share for the financial year ended March 31, 2025. This announcement reflects Alibaba’s commitment to returning value to its shareholders and may have implications for the company’s financial strategy and stakeholder confidence. The dividend will be paid on July 3, 2025, with the record date set for June 12, 2025.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.
Alibaba Group announced its financial results for the March quarter and fiscal year 2025, highlighting significant growth driven by its ‘user first, AI-driven’ strategy. The company reported a 7% increase in quarterly revenue and a 36% rise in EBITA, with AI-related product revenue achieving triple-digit growth for the seventh consecutive quarter. Alibaba also repurchased $11.9 billion of shares, reducing outstanding shares by 5.1%, and declared dividends totaling $4.6 billion, reflecting a strong commitment to enhancing shareholder returns.
The most recent analyst rating on (HK:9988) stock is a Buy with a HK$117.00 price target. To see the full list of analyst forecasts on Alibaba Group Holding Ltd. stock, see the HK:9988 Stock Forecast page.